Company: VERA
Filing Date: 2025-01-13
Form Type: 8-K
Source: 0001193125-25-005010
Chunk: 0

Company: Vera Therapeutics, Inc.
Filing Date: 2025-01-13
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01      Regulation FD Disclosure.  

On January 13, 2025, Vera Therapeutics, Inc. (the “ Company”) released an updated corporate presentation entitled “ J. P. Morgan Healthcare Conference”. The presentation is available on the Company’s website, and a copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form8-K. For important information about forward-looking statements, see the slide titled “ Forward Looking Statements” in Exhibit 99.1 attached hereto.

The information set forth in this Item 7.01 and Exhibit 99.1 shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section. The information contained in this Item 7.01 and in the accompanying exhibit shall not be incorporated by reference into any filing with the U. S. Securities and Exchange Commission made by the Company under the Exchange Act or the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.